Remedy Entertainment Oyj Full Year 2022 Earnings: EPS Misses Expectations

Simply Wall St

February 12, 2023

Remedy Entertainment Oyj (HEL:REMEDY) Full Year 2022 Results

Key Financial Results

Revenue: €43.6m (down 18% from FY 2021).
Net loss: €1.73m (down by 116% from €10.8m profit in FY 2021).
€0.13 loss per share (down from €0.81 profit in FY 2021).

earnings-and-revenue-growth — HLSE:REMEDY Earnings and Revenue Growth February 12th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Remedy Entertainment Oyj EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.4%.

Looking ahead, revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Entertainment industry in Europe.

Performance of the market in Finland.

The company's shares are up 2.7% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Remedy Entertainment Oyj that you should be aware of.

If you're looking to trade Remedy Entertainment Oyj, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.